Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration [Docket No. 01N-0183]
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Notice.
 SUMMARY: The Food and Drug Administration (FDA) is withdrawing approval of 13 new animal drug applications (NADAs) listed below at the request of the sponsor.  In a final rule published elsewhere in this issue of the 
                        **Federal Register**
                        , FDA is amending the animal drug regulations by removing the portions reflecting approval of the NADAs.
 DATES: Withdrawal of approval is effective May 14, 2001.
 FOR FURTHER INFORMATION CONTACT: Pamela K. Esposito, Center for Veterinary Medicine (HFV-210), Food and Drug Administration, 7500 Standish Pl., Rockville, MD   20855, 301-827-5593.


SUPPLEMENTARY INFORMATION: The following sponsors have requested that FDA withdraw approval of the NADAs listed below because the products are no longer manufactured or marketed: Sponsor
NADA Number Product (Drug)
21 CFR Cite Affected 
                             (Sponsor Drug Labeler Code)Elanco Animal Health, A Div. of Eli Lilly & Co., Lilly Corporate Center, Indianapolis, IN 46285
NADA 12-585 Tylan Injectable (tylosin tartrate)
522.2640b (000986)NADA 15-207 Hyferdex Injection (iron dextran complex)
522.1183(c) (000986)( print page 22236)NADA 30-330 Tylocine Sulfa Tablets (sulfadiazine, sulfamerazine, sulfamethazine, tylosin)
not applicableNADA 31-962 Tylan plus Neomycin Eye Powder (neomycin sulfate, tylosin)
524.2640 (000986)NADA 40-123 Toptic Ointment (cephalonium, flumethasone, iodochlorhydroxyquin, piperocaine hydrochloride, polymyxin B sulfate)
524.321 (000986)NADA 47-092 Tribodine (ticarbodine)
520.2460a (000986)NADA 47-353 Ferti-Cept (chorionic gonadotropin)
522.1081(b) (000986)NADA 92-602 Cephalothin Discs (cephaloridine)
529.360 (000986)NADA 96-678 Tribodine Capsules (ticarbodine)
520.2460b (000986)Bioproducts, Inc., 320 Springside Dr., suite 300, Fairlawn, OH 44333-2435
NADA 93-518 Tylan® 10 Plus (tylosin phosphate)
558.625(b)(2)  (051359)Young’s Inc., Roaring Spring, PA 16673
NADA 96-162 Hog Grow-R-Mix-4000, Hog Grow-R-Mix-800 (tylosin phosphate)
558.625(b)(13) (035393)Veterinary Laboratories, Inc., 12340 Santa Fe Dr., Lenexa, KS 66215
NADA 42-889 Oxytocin Injection (oxytocin)
522.1680(b) (000857)Webel Feeds, Inc., R.R. 3, Pittsfield, IL 62363
NADA 116-196 Webel Tylan Premix (tylosin phosphate)
558.625(b)(73) (035098)
 Therefore, under authority delegated to the Commissioner of Food and Drugs (21 CFR 5.10), redelegated to the Center for Veterinary Medicine (21 CFR 5.84), and in accordance with § 514.115 
                    *Withdrawal of approval of applications*
                     (21 CFR 514.115), notice is given that approval of NADAs 12-585, 15-207, 30-330, 31-962, 40-123, 42-889, 47-092, 47-353, 92-602, 93-518, 96-162, 96-678, and 116-196, and all supplements and amendments thereto, is hereby withdrawn, effective May 14, 2001. In a final rule published elsewhere in this issue of the 
                    **Federal Register**
                    , FDA is amending the animal drug regulations by removing those portions that reflect approval of the NADAs. Dated: April 23, 2001. Linda Tollefson, Deputy Director, Center for Veterinary Medicine.


[FR Doc. 01-11071 Filed 5-2-01; 8:45 am] BILLING CODE 4160-01-S